- Home
- WST vs FE Comparison
WST vs FE Comparison
Compare WST & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- FE
- Stock Information
- Founded
- WST 1923
- FE 1996
- Country
- WST United States
- FE United States
- Employees
- WST N/A
- FE N/A
- Industry
- WST Medical/Dental Instruments
- FE Electric Utilities: Central
- Sector
- WST Health Care
- FE Utilities
- Exchange
- WST Nasdaq
- FE Nasdaq
- Market Cap
- WST 15.6B
- FE N/A
- IPO Year
- WST N/A
- FE N/A
- Fundamental
- Price
- WST $216.71
- FE $39.93
- Analyst Decision
- WST Buy
- FE Buy
- Analyst Count
- WST 7
- FE 15
- Target Price
- WST $331.67
- FE $46.15
- AVG Volume (30 Days)
- WST 690.0K
- FE 5.4M
- Earning Date
- WST 07-24-2025
- FE 07-29-2025
- Dividend Yield
- WST 0.38%
- FE 4.43%
- EPS Growth
- WST N/A
- FE 1.45
- EPS
- WST 6.37
- FE 1.88
- Revenue
- WST $2,895,800,000.00
- FE $13,764,000,000.00
- Revenue This Year
- WST $3.38
- FE $9.20
- Revenue Next Year
- WST $5.85
- FE $3.82
- P/E Ratio
- WST $34.31
- FE $21.36
- Revenue Growth
- WST N/A
- FE 8.03
- 52 Week Low
- WST $187.43
- FE $37.58
- 52 Week High
- WST $352.33
- FE $44.97
- Technical
- Relative Strength Index (RSI)
- WST 48.20
- FE 40.70
- Support Level
- WST $215.67
- FE $39.28
- Resistance Level
- WST $223.77
- FE $40.72
- Average True Range (ATR)
- WST 4.99
- FE 0.56
- MACD
- WST -0.52
- FE 0.01
- Stochastic Oscillator
- WST 19.10
- FE 40.12
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.